A Insider Report for Aileron Therapeutics, Inc. (ALRN)

Role: 10%+ Owner
Signature: /s/ Joan Moeller, Chief Operating Officer
Stock symbol: ALRN
Transactions as of: May 1, 2024
Transactions value $: -$85,473
Form type: 4/A
Date filed: 5/14/2024, 05:54 PM
Date Of Original Report: May 1, 2024
Previous filing: Apr 30, 2024
Next filing: Jun 7, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALRN	Common Stock	Sale	-$12.7K	-3.1K	-0.17%	$4.10	1.81M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$411	-100	-0.01%	$4.11	1.81M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$7.21K	-1.75K	-0.1%	$4.12	1.81M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$1.57K	-380	-0.02%	$4.13	1.81M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$6.63K	-1.6K	-0.09%	$4.15	1.8M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$2.78K	-670	-0.04%	$4.15	1.8M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$1.67K	-400	-0.02%	$4.18	1.8M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$33.7K	-7.92K	-0.44%	$4.25	1.79M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$1.32K	-310	-0.02%	$4.26	1.79M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$1.35K	-317	-0.02%	$4.27	1.79M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$427	-100	-0.01%	$4.27	1.79M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$855	-200	-0.01%	$4.28	1.79M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$1.44K	-337	-0.02%	$4.28	1.79M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$857	-200	-0.01%	$4.29	1.79M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$12.5K	-2.9K	-0.16%	$4.29	1.79M	May 1, 2024	Direct	F1
transaction	ALRN	Common Stock	Sale	-$108	-25	0%	$4.32	1.79M	May 1, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.

Content

Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.

Remarks:

On May 1, 2024, the Reporting Person filed a Form 4 that, due to an administrative error, reported sales on April 29, 2024, and April 30, 2024, that were not executed. This amendment is being filed solely to remove such sales and correct the resulting amount of shares reported as beneficially owned by the Reporting Person following the transactions reported herein.